SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001193125-24-122192
Filing Date
2024-04-29
Accepted
2024-04-29 16:02:37
Documents
16
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 10-K/A d831708d10ka.htm   iXBRL 10-K/A 381007
2 EX-31.1 d831708dex311.htm EX-31.1 4669
  Complete submission text file 0001193125-24-122192.txt   639286

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA elym-20231231.xsd EX-101.SCH 4590
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE elym-20231231_cal.xml EX-101.CAL 667
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE elym-20231231_def.xml EX-101.DEF 17104
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE elym-20231231_lab.xml EX-101.LAB 23156
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE elym-20231231_pre.xml EX-101.PRE 18661
20 EXTRACTED XBRL INSTANCE DOCUMENT d831708d10ka_htm.xml XML 6164
Mailing Address 2801 CENTERVILLE ROAD 1ST FLOOR PMB #117 WILMINGTON DE 19808
Business Address 2801 CENTERVILLE ROAD 1ST FLOOR PMB #117 WILMINGTON DE 19808 877-354-3689
Eliem Therapeutics, Inc. (Filer) CIK: 0001768446 (see all company filings)

IRS No.: 832273741 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-40708 | Film No.: 24890513
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)